Currently an exhibitor? Visit our Exhibitor Resource Center for up-to-date information.

Diabetes in Depth Baltimore 2009

Location: Baltimore, MD
Date: April 30, 2009

Meeting Overview

Venue:
Hilton Baltimore
Primary Audience:
Primary Care
Credits:
9 AMA PRA Category 1 CreditsTM, AAFP, 9 AANP

Primary Care Approaches to Managing the Complexities of Diabetes 

Diabetes In Depth is a 1-day CME program presented by Pri-Med in collaboration with the American Diabetes Association. At the program, expert faculty will present clinically relevant practice and patient care issues in diabetes diagnosis and treatment. Our interactive sessions and workshops are aimed to better help you educate and manage your diabetic patients. 


Session and Workshop Topics Include:

  • Keynote Address: Current Strategies for the Prevention and Management of Cardiometabolic Complications in People With Diabetes
  • Use of Screening and Diagnostic Tools to Identify Patients with/or At Increased Risk for Diabetes
  • The Role of Incretin-Based Therapies in the Management of Diabetic Hyperglycemia
  • Managing Hypertension in Diabetic Patients
  • Team Approaches to Managing Diabetic Complications and Comorbidities: Obesity, Depression, Sleep Apnea, and Diabetic Foot

In addition to the live meeting, the multichannel curriculum includes online activities related to the topics presented. Online activities include patient case studies, expert perspectives, and slide lectures.


Attending will help you understand how to

  • Assess treatment strategies and implement patient-specific directed therapies.
  • Analyze the methods and role of intensive glycemic control through early intervention and treatment advancement.
  • Address multifactorial cardiovascular risk in the patient with diabetes, and strategies to manage cardiometabolic risk factors.
  • Incorporate essential clinical management tools, including self-monitoring of blood glucose, medical nutritional therapy, and patient education.
  • Explore emerging and new perspectives in the treatment of diabetes.


What Our Alumni Are Saying 

“This program was very beneficial as a review of new treatments, and for alerting patients of current thinking on management of diabetes.”
R. Hall, MD

“Diabetes In Depth is excellent. It covers everything from ethnicity variations to the most up-to-date diabetes treatment options.”
R. Daida, MD


Additional CME Meetings 

Diabetes In Depth National Schedule | Available CME Meetings for Primary Care Clinicians

Marketing Partners

Pri-Med partners with local healthcare associations, managed care organizations, and publications in order to ensure that all practicing clinicians have the opportunity to attend. Pri-Med would like to thank the following partners for this program to date: Aetna, and American Academy of Nurse Practitioners.

Educational Grants

To date, the following organizations have provided educational grants in support of this Pri-Med activity: Amylin Pharmaceuticals, Inc. and Eli Lilly and Company , Bristol-Myers Squibb and AstraZeneca Pharmaceuticals LP, Alliance Partners, Merck & Co., Inc., and Novo Nordisk Inc..

Session Summary

Following is a recap of the core educational elements from the conference sessions, to help you take what you learned and apply it to your interactions with patients.

View Schedule for:
Thursday, April 30, 2009
7:45 AM-8:45 AM
Keynote Address: Current Strategies for the Prevention and Management of Cardiometabolic Complications in People with Diabetes

Description:

1. Describe how early prevention, identification and treatment of diabetes and cardiometabolic disease will improve patient outcomes through reducing risk and progression of microvascular and macrovascular complications. 2. Recognize the various components of cardiometabolic disease and understand how to utlize non-pharmacologic and pharmacologic strategies to effectively manage cardiometabolic risk and disease in diabetic diabetes.
Lawrence Blonde, FACE, MD, FACP, Director, Ochsner Diabetes Clinical Research Unit, Department of Endocrinology, Associate Residency Program Director, Department of Internal Medicine, Ochsner Medical Center, New Orleans, LA
8:45 AM-9:30 AM
Use of Screening and Diagnostic Tools to Identify Patients with or at Increased Risk for Diabetes

Description:

1. Identify and increase the use of tools for screening, diagnosing, monitoring and better managing diabetic patients and their comorbidities. 2. Describe 5 preventive measures for diabetes and the potential impact on the reducing A1C levels and associated cardiovascular risks.
Anne Peters, MD, Director, USC Clinical Diabetes Programs, Professor, USC Keck School of Medicine, USC Westside Center for Diabetes, Los Angeles, CA

Related CME

Featured CME Activities Format Credits Expires Status
Diagnosing Type 2 Diabetes Mellitus Using the A1C Assay Expert Perspective 1 AMA1
1 AANP
1 ANCC
 08/31/2010
Assessing the 5-Year Risk for Type 2 Diabetes Using Multiple Biomarkers Expert Perspective 1 AMA1
1 ANCC
1 AANP
 11/05/2010
9:45 AM-10:45 AM
The First Step: Managing Diabetic Hyperglycemia With Therapeutic Lifestyle Changes and Basic Oral Agents

Description:

1. Understand primary approaches to the effective management of recently diagnosed patients with diabetes and the how non-pharmacologic and pharmacologic strategies can provide improved glycemic control and reduce cardiometabolic risk. 2. Develop skills to overcome patient and cultural barriers by successfully educating patients to aggressively manage their disease while providing on-going support to prevent and better manage their diabetes.
Linda M Delahanty, MS, RD, Chief Dietitian and Director of Nutrition and Behavioral Research, Massachusetts General Hospital Diabetes Center, Boston, MA
10:45 AM-12:00 PM
The Second Step: Progression of Treatment With Combinations of Oral Antihyperglycemic Agents

Description:

1. Describe the cumulative effect of using multiple non-insulin agents to treat diabetic patients and how their combined use can impact overall glycemic management and cardiovascular risk. 2. Name 3 combination drug regimens, when to specifically initiate treatment, and their role in improving glucose control through adherence to guidelines.
Michelle Magee, MD, MBBCh, BAO, Director, MedStar Diabetes Institute (MDI), Associate Professor of Medicine, Georgetown University School of Medicine, Washington, DC

Related CME

Featured CME Activities Format Credits Expires Status
Exploring Reports Suggesting a Possible Link Between Insulin Glargine and Cancer Risk Expert Perspective .5 AMA1
 10/19/2010
12:10 PM-1:10 PM
Working Lunch: The Role of Incretin-Based Therapies in the Management of Diabetic Hyperglycemia

Description:

1. Realize the utility of incretin based therapies through understanding incretin glucoregulatory pathophysiology and mechanisms of action as a monotherapy or in combination with other non-insulin agents to better control glycemia. 2. Describe 2 classes of incretin-based therapies, their benefits and risks to use, and how they can be implemented in patient-specific scenarios to improve glycemic levels according to guidelines.
Richard E Pratley, MD, Professor of Medicine, University of Vermont College of Medicine, Burlington, VT
1:20 PM-2:05 PM
Insulin Therapy: Best Practices

Description:

1. Describe 3 specific methods to overcome patient and/or clinician barriers to utilizing insulin and ensuring adherence to the therapeutic regimen. 2. Differentiate commercially available insulin preparations and how to implement patient-specific insulin therapy to improve glycemic control and achieve glycemic targets. 3. Discuss the benefits of combining insulin with non-insulin OADs therapies, its use, risks, and how a step-wise implementation of insulin will improve glycemic control in type 2 diabetic patients.
Jack L. Leahy, MD, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Vermont College of Medicine, Burlington, VT
2:05 PM-3:05 PM
Case-Based Workshop: Effective Use of Insulin

Description:

1. Describe how to appropriately initiate insulin, intensify and how to change dosing based on type of insulin, glucose log, carbohydrate counting, and estimated exercise/activity. 2. Understand patient case-based examples of how to effectively utilize insulin while preventing urgent and emergent problems from developing.
Jack L. Leahy, MD, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Vermont College of Medicine, Burlington, VT
3:15 PM-3:45 PM
Managing Hypertension in Diabetic Patients

Description:

1. Recognize the association between insulin resistance and cardiovascular disease in patients with diabetes and which drug combinations for blood pressure and glycemic control work best. 2. Recognize the relationship between metabolic syndrome and CVD and identify the earlier manifestations of microvascular /macrovascular hypertension while understanding optimal ways to effectively manage.
Alan H. Gradman, MD, Division of Cardiovascular Diseases, The Western Pennsylvania Hospital, Pittsburgh, PA
3:45 PM-4:15 PM
Managing Dyslipidemia in Diabetic Patients

Description:

1. Understand and outline the pleiotropic effects of dyslipidemia therapies (i.e.; statins, fibrates, omega 3s, bile acid sequestrants, etc) as a viable clinical intervention in the areas of CHD and CV risk, and become competent in the initiation and utilization of patient specific management strategies 2.Understand the complexity of hypertriglyceridemia and non-HDL-C, the importance or effective management and its potential impact on cardiovascular outcomes for your diabetic patients.
Alan H. Gradman, MD, Division of Cardiovascular Diseases, The Western Pennsylvania Hospital, Pittsburgh, PA

Related CME

Featured CME Activities Format Credits Expires Status
The Role of Bile Acid Sequestrants in Managing Cardiovascular Risk in Type 2 Diabetes Expert Perspective 1 AMA1
1 AANP
1 ANCC
 08/28/2010
4:15 PM-5:30 PM
Team Approaches to Managing Diabetic Complications and Comorbidities: Obesity, Depression, Sleep Apnea, Diabetic Foot

Description:

1. Understand the important implications that Obesity, Depression, Sleep Apnea, Foot complications have on the diabetic patient and ways in which one can both effectively prevent, diagnose and treat these clinical concerns. 2. Identify & understand effective practice tools to better assess and manage the complexities of the diabetic patient, as well as educate patients in ways to prevent and recognize complications before they progress to negatively impact health.
Frank Lavernia, MD, Founder, North Broward Diabetes Center, Pompano Beach, FL
Michael E. Cobble, MD, Director, Canyons Medical Center, Sandy, UT

Accreditation

Academic Partner

Pri-Med Institute gratefully acknowledges the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute for serving as academic partners in the review of educational content.

Statement of Independence

This educational program is conceived and credited in accordance with ACCME’s Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute’s Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.

Credits Type Accreditation Statement Designation Statement
9 AMA PRA Category 1 Credits™ Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Pri-Med Institute designates this educational activity for a maximum of 9 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
9 AANP Pri-Med Institute is approved as a provider of nurse practitioner continuing education programs by the American Academy of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 9 contact hour of continuing education , which includes 4.500 hours of pharmacology.
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Hilton Baltimore
401 W Pratt St
Baltimore, MD 21201-1629
(443)573-8700
Hilton Baltimore web site

Hotel Accommodations

A limited number of rooms have been reserved at the Hilton Baltimore. Please call (443)573-8700 by 04/06/2009 and identify yourself as a Diabetes In Depth attendee to receive the discounted rate of $209.

Parking: Please click on the link below for a map and parking information:

http://www1.hilton.com/en_US/hi/hotel/BWICCHH-Hilton-Baltimore-Maryland/directions.do#localmap

Syllabus Materials

Update: For this program, there will be a hard-copy of the syllabus provided onsite. No electronic syllabus will be available.

Related CME

April 30, 2009

Featured Activities Format Credits ExpiresStatus
Assessing the 5-Year Risk for Type 2 Diabetes Using Multiple BiomarkersExpert Perspective1 AMA1
1 ANCC
1 AANP
11/05/2010
Exploring Reports Suggesting a Possible Link Between Insulin Glargine and Cancer RiskExpert Perspective0.5 AMA1
10/19/2010
Diagnosing Type 2 Diabetes Mellitus Using the A1C AssayExpert Perspective1 AMA1
1 AANP
1 ANCC
08/31/2010
The Role of Bile Acid Sequestrants in Managing Cardiovascular Risk in Type 2 DiabetesExpert Perspective1 AMA1
1 AANP
1 ANCC
08/28/2010

Additional Meetings

??
Other Recommended Meetings

Pri-Med Access with ACP in Cincinnati, OH - March 17, 2010 - March 18, 2010

Cincinnati, OH

Meeting Overview | Register now | Add to my Outlook Calendar

Current Concepts in Diabetes - Cleveland, OH - March 26, 2010

Cleveland, OH

Meeting Overview | Register now | Add to my Outlook Calendar

Pri-Med Access with ACP in Boston, MA - April 7, 2010 - April 8, 2010

Boston, MA

Meeting Overview | Register now | Add to my Outlook Calendar

Additional Opportunities